Literature DB >> 17996970

Expression of the porcine circovirus type 2 capsid protein subunits and application to an indirect ELISA.

Pei-Ching Wu1, Maw-Sheng Chien, Yu-Yao Tseng, Jiarong Lin, Wei-Li Lin, Cheng-Yao Yang, Chienjin Huang.   

Abstract

Porcine circovirus type 2 (PCV2) is considered to be associated with post-weaning multisystemic wasting syndrome (PMWS), which is a newly emerged economically important swine disease. The entire coding region of open reading frame 2 (ORF2), encoding the viral capsid protein (Cap), of PCV2 was cloned and sequenced from the clinical specimen obtained from PMWS-affected piglets. Six recombinant subunits, A-F, spanning the defined regions of Cap were produced by E. coli expression system and used as antigens for testing their reactivities with swine sera in the indirect ELISA. The recombinant Cap subunit-based ELISA was evaluated by examining a panel of 12 PCV2-negative and 26 PCV2-positive sera. When the positive/negative cut-off value was set at the mean value of negative sera plus 3 standard deviations, all subunits-based ELISA demonstrated 100% specificities. The N-terminal subunits, A and B, revealed poor reactivity with positive swine sera, whereas, greater immunoreactivity was observed for the C-terminal subunits of which subunits C and D demonstrated good sensitivities of 96.2% and 84.6%, respectively. The recombinant Cap subunits possessing defined antigenicity are easy to produce and the subunit-based ELISA was developed with a high specificity and sensitivity that may provide a useful method for routine serodiagnosis of PCV2 infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17996970     DOI: 10.1016/j.jbiotec.2007.09.015

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  8 in total

1.  Development and application of a double-antigen sandwich enzyme-linked immunosorbent assay for detection of antibodies to porcine circovirus 2.

Authors:  Meng Ge; Wei Luo; Daliang Jiang; Runcheng Li; Wenwei Zhao; Guoliang Chen; Xingdong Yang; Xinglong Yu
Journal:  Clin Vaccine Immunol       Date:  2012-07-18

2.  Prokaryotic expression and potential application of the truncated PCV-2 capsid protein.

Authors:  Zhong-zi Lou; Zhi-yong Li; Gang Wang; Jian-qiang Li; Xi Lan; Xue-rui Li; Xiang-ping Yin; Ji-xing Liu; Si-dang Liu
Journal:  Virol Sin       Date:  2010-04-09       Impact factor: 4.327

3.  Self-assembly of virus-like particles of porcine circovirus type 2 capsid protein expressed from Escherichia coli.

Authors:  Shuanghui Yin; Shiqi Sun; Shunli Yang; Youjun Shang; Xuepeng Cai; Xiangtao Liu
Journal:  Virol J       Date:  2010-07-21       Impact factor: 4.099

4.  In vitro expression and development of indirect ELISA for Capsid protein of duck circovirus without nuclear localization signal.

Authors:  Yanyan Lu; Renyong Jia; Zhilong Zhang; Mingshu Wang; Yu Xu; Dekang Zhu; Shun Chen; Mafeng Liu; Zhongqiong Yin; Xiaoyue Chen; Anchun Cheng
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

5.  The Porcine Circovirus Type 2 Nonstructural Protein ORF3 Induces Apoptosis in Porcine Peripheral Blood Mononuclear Cells.

Authors:  Wei-Li Lin; Maw-Sheng Chien; Pei-Ching Wu; Chen-Li Lai; Chienjin Huang
Journal:  Open Virol J       Date:  2011-12-13

6.  Heterologous expression of full-length capsid protein of porcine circovirus 2 in Escherichia coli and its potential use for detection of antibodies.

Authors:  Zuzana Marcekova; Ivan Psikal; Eva Kosinova; Oldrich Benada; Peter Sebo; Ladislav Bumba
Journal:  J Virol Methods       Date:  2009-08-05       Impact factor: 2.014

7.  Development and validation of a competitive ELISA based on virus-like particles of serotype Senecavirus A to detect serum antibodies.

Authors:  Manyuan Bai; Rui Wang; Shiqi Sun; Yun Zhang; Hu Dong; Huichen Guo
Journal:  AMB Express       Date:  2021-01-06       Impact factor: 3.298

8.  Generation in yeast of recombinant virus-like particles of porcine circovirus type 2 capsid protein and their use for a serologic assay and development of monoclonal antibodies.

Authors:  Juozas Nainys; Rita Lasickiene; Rasa Petraityte-Burneikiene; Jonas Dabrisius; Raimundas Lelesius; Vilimas Sereika; Aurelija Zvirbliene; Kestutis Sasnauskas; Alma Gedvilaite
Journal:  BMC Biotechnol       Date:  2014-12-09       Impact factor: 2.563

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.